Review




Structured Review

Proteintech cyclin d2
Cyclin D2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 73 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclin+d2+antibody/pm41683655-165-10-12?v=Proteintech
Average 94 stars, based on 73 article reviews
cyclin d2 - by Bioz Stars, 2026-07
94/100 stars

Images



Similar Products

94
Santa Cruz Biotechnology cyclin d2
Cyclin D2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclin+d2+antibody/pm41856058-70-31-34?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
cyclin d2 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
Proteintech cyclin d2
Cyclin D2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclin+d2+antibody/pm41683655-165-10-12?v=Proteintech
Average 94 stars, based on 1 article reviews
cyclin d2 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
Proteintech ccnd2
Ccnd2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclin+d2+antibody/pm41361309-154-84-85?v=Proteintech
Average 94 stars, based on 1 article reviews
ccnd2 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

86
Affinity Biosciences anti cyclin d2 antibody
( A, B ) The transfection efficiency of pCD25-circSIK2, pCD25-circSIK2-MT( A ), and siRNAs ( B ) for circSIK2 ( n = 4). ( C, D ) CCK-8 assay was performed to assess the effect of circSIK2 overexpression and knockdown on myoblast proliferation ( n = 8). ( E ) The statistical results of cell cycle analysis after overexpression and inhibition of circSIK2 in myoblast ( n = 4). ( F, I ) The proliferation rate ( F ) and EdU staining ( I ) of myoblast cells transfected with pCD25-circSIK2, pCD25-circSIK2-MT, and si1-circSIK2 ( n = 4). ( G, H ) mRNA level of CDKN1A , CDKN1B , <t>Cyclin</t> <t>D2</t> , and PCNA after overexpression and knockdown of circSIK2 ( n = 4). ( J, K ) The protein expression of CDKN1A, CDKN1B, and Cyclin D2 ( J ) and their relative grey value ( K ) was determined by western blot in myoblast cells ( n = 3), western blot was from an aliquot of the same sample but were run and blotted from different gels (*P < 0.05; **P < 0.01, ***P < 0.001).
Anti Cyclin D2 Antibody, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclin+d2+antibody/pmc12578262-296-31-35?v=Affinity+Biosciences
Average 86 stars, based on 1 article reviews
anti cyclin d2 antibody - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology anti cyclin d2
( A, B ) The transfection efficiency of pCD25-circSIK2, pCD25-circSIK2-MT( A ), and siRNAs ( B ) for circSIK2 ( n = 4). ( C, D ) CCK-8 assay was performed to assess the effect of circSIK2 overexpression and knockdown on myoblast proliferation ( n = 8). ( E ) The statistical results of cell cycle analysis after overexpression and inhibition of circSIK2 in myoblast ( n = 4). ( F, I ) The proliferation rate ( F ) and EdU staining ( I ) of myoblast cells transfected with pCD25-circSIK2, pCD25-circSIK2-MT, and si1-circSIK2 ( n = 4). ( G, H ) mRNA level of CDKN1A , CDKN1B , <t>Cyclin</t> <t>D2</t> , and PCNA after overexpression and knockdown of circSIK2 ( n = 4). ( J, K ) The protein expression of CDKN1A, CDKN1B, and Cyclin D2 ( J ) and their relative grey value ( K ) was determined by western blot in myoblast cells ( n = 3), western blot was from an aliquot of the same sample but were run and blotted from different gels (*P < 0.05; **P < 0.01, ***P < 0.001).
Anti Cyclin D2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclin+d2+antibody/bio_rxiv__2025__10__23__684166-53-20-22?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
anti cyclin d2 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
Proteintech anti ccnd2
( A, B ) The transfection efficiency of pCD25-circSIK2, pCD25-circSIK2-MT( A ), and siRNAs ( B ) for circSIK2 ( n = 4). ( C, D ) CCK-8 assay was performed to assess the effect of circSIK2 overexpression and knockdown on myoblast proliferation ( n = 8). ( E ) The statistical results of cell cycle analysis after overexpression and inhibition of circSIK2 in myoblast ( n = 4). ( F, I ) The proliferation rate ( F ) and EdU staining ( I ) of myoblast cells transfected with pCD25-circSIK2, pCD25-circSIK2-MT, and si1-circSIK2 ( n = 4). ( G, H ) mRNA level of CDKN1A , CDKN1B , <t>Cyclin</t> <t>D2</t> , and PCNA after overexpression and knockdown of circSIK2 ( n = 4). ( J, K ) The protein expression of CDKN1A, CDKN1B, and Cyclin D2 ( J ) and their relative grey value ( K ) was determined by western blot in myoblast cells ( n = 3), western blot was from an aliquot of the same sample but were run and blotted from different gels (*P < 0.05; **P < 0.01, ***P < 0.001).
Anti Ccnd2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cyclin+d2+antibody/pmc12484796-326-22-25?v=Proteintech
Average 94 stars, based on 1 article reviews
anti ccnd2 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

Image Search Results


( A, B ) The transfection efficiency of pCD25-circSIK2, pCD25-circSIK2-MT( A ), and siRNAs ( B ) for circSIK2 ( n = 4). ( C, D ) CCK-8 assay was performed to assess the effect of circSIK2 overexpression and knockdown on myoblast proliferation ( n = 8). ( E ) The statistical results of cell cycle analysis after overexpression and inhibition of circSIK2 in myoblast ( n = 4). ( F, I ) The proliferation rate ( F ) and EdU staining ( I ) of myoblast cells transfected with pCD25-circSIK2, pCD25-circSIK2-MT, and si1-circSIK2 ( n = 4). ( G, H ) mRNA level of CDKN1A , CDKN1B , Cyclin D2 , and PCNA after overexpression and knockdown of circSIK2 ( n = 4). ( J, K ) The protein expression of CDKN1A, CDKN1B, and Cyclin D2 ( J ) and their relative grey value ( K ) was determined by western blot in myoblast cells ( n = 3), western blot was from an aliquot of the same sample but were run and blotted from different gels (*P < 0.05; **P < 0.01, ***P < 0.001).

Journal: PLOS Genetics

Article Title: METTL3 facilitates the translation of CircSIK2 during chicken myogenesis in an m 6 A dependent manner

doi: 10.1371/journal.pgen.1011934

Figure Lengend Snippet: ( A, B ) The transfection efficiency of pCD25-circSIK2, pCD25-circSIK2-MT( A ), and siRNAs ( B ) for circSIK2 ( n = 4). ( C, D ) CCK-8 assay was performed to assess the effect of circSIK2 overexpression and knockdown on myoblast proliferation ( n = 8). ( E ) The statistical results of cell cycle analysis after overexpression and inhibition of circSIK2 in myoblast ( n = 4). ( F, I ) The proliferation rate ( F ) and EdU staining ( I ) of myoblast cells transfected with pCD25-circSIK2, pCD25-circSIK2-MT, and si1-circSIK2 ( n = 4). ( G, H ) mRNA level of CDKN1A , CDKN1B , Cyclin D2 , and PCNA after overexpression and knockdown of circSIK2 ( n = 4). ( J, K ) The protein expression of CDKN1A, CDKN1B, and Cyclin D2 ( J ) and their relative grey value ( K ) was determined by western blot in myoblast cells ( n = 3), western blot was from an aliquot of the same sample but were run and blotted from different gels (*P < 0.05; **P < 0.01, ***P < 0.001).

Article Snippet: The other primary antibodies used for western blots were as follow: anti-flag antibody (Transgen Biotech, China), anti-CDKN1A antibody (bs0741R, Bioss, China), anti-CDKN1B antibody (bs0742R, Bioss, China), anti-CDKN2B antibody (bs4269R, Bioss, China), anti-Cyclin D2 antibody (AF5410, Affinity Biosciences, USA), anti-IGF1R antibody (bs0680R, Bioss, China), anti-INSR antibody (bs0681R, Bioss, China), anti-AKT1 (#9272, Cell Signaling Technology), anti-phospho-AKT1 (#4040, Cell Signaling Technology), anti-MyoD (ab16148, Abcam), anti-MyHC (B103, Developmental Studies Hybridoma Bank), anti-HNRNPA2B1 (Fab6995, Hunan Fenghui Biotechnology), anti-GAPDH (MB001, Bioworld Technology), anti-Tubulin (MB0009, Bioworld Technology).

Techniques: Transfection, CCK-8 Assay, Over Expression, Knockdown, Cell Cycle Assay, Inhibition, Staining, Expressing, Western Blot

( A ) SIK2-176aa promotes the mRNA level of CDKN1A , CDKN1B , CDKN2B , Cyclin D2 , and PCNA . ( B ) The protein expression of CDKN1A, CDKN1B, CDKN2B, and Cyclin D2 was determined by western blot in myoblast cells. ( C ) The statistical results of cell cycle analysis after overexpression of SIK2-176aa. ( D, R ) The EdU staining ( D ) and proliferation rate ( E ) of myoblast cells transfected with pCD3.1-SIK2-176aa-FLAG. ( F, G ) Myotube area ( F ) and MyHC staining ( G ) after transfected with pCD3.1-SIK2-176aa-FLAG. ( H ) SIK2-176aa promotes the mRNA level of GHR-IGF-AKT pathway genes including GHR , IGF2 , IGF1R , INSR , AKT1 , and the myogenic regulatory factor family member including MyoD , MyoG , MyHC , Myomaker , Myf5 , and Myf6 . ( K ) H-E staining of breast muscle fiber cross section infected with LV5-SIK2-176aa or LV5-Control (upper panel) and the statistical data of muscle fiber diameter and cross-sectional area (lower panel). Lentivirus was injected three times into the pectoral muscles of 1-day-old chicks (n = 10) at days 1, 4, and 7 at a dosage of 1 × 10 8 IU/mL. The pectoral muscles were obtained 14 days after the first injection. ( L ) q-RT PCR detection of the injection efficiency of LV5-SIK2-176aa. ( I-J, M-N ) SIK2-176aa promotes the protein expression of IGF1R, INSR, p-AKT1, MyoD, and MyHC in vivo ( I-J ) and in vitro ( M-N ), western blot was from an aliquot of the same sample but were run and blotted from different gels.

Journal: PLOS Genetics

Article Title: METTL3 facilitates the translation of CircSIK2 during chicken myogenesis in an m 6 A dependent manner

doi: 10.1371/journal.pgen.1011934

Figure Lengend Snippet: ( A ) SIK2-176aa promotes the mRNA level of CDKN1A , CDKN1B , CDKN2B , Cyclin D2 , and PCNA . ( B ) The protein expression of CDKN1A, CDKN1B, CDKN2B, and Cyclin D2 was determined by western blot in myoblast cells. ( C ) The statistical results of cell cycle analysis after overexpression of SIK2-176aa. ( D, R ) The EdU staining ( D ) and proliferation rate ( E ) of myoblast cells transfected with pCD3.1-SIK2-176aa-FLAG. ( F, G ) Myotube area ( F ) and MyHC staining ( G ) after transfected with pCD3.1-SIK2-176aa-FLAG. ( H ) SIK2-176aa promotes the mRNA level of GHR-IGF-AKT pathway genes including GHR , IGF2 , IGF1R , INSR , AKT1 , and the myogenic regulatory factor family member including MyoD , MyoG , MyHC , Myomaker , Myf5 , and Myf6 . ( K ) H-E staining of breast muscle fiber cross section infected with LV5-SIK2-176aa or LV5-Control (upper panel) and the statistical data of muscle fiber diameter and cross-sectional area (lower panel). Lentivirus was injected three times into the pectoral muscles of 1-day-old chicks (n = 10) at days 1, 4, and 7 at a dosage of 1 × 10 8 IU/mL. The pectoral muscles were obtained 14 days after the first injection. ( L ) q-RT PCR detection of the injection efficiency of LV5-SIK2-176aa. ( I-J, M-N ) SIK2-176aa promotes the protein expression of IGF1R, INSR, p-AKT1, MyoD, and MyHC in vivo ( I-J ) and in vitro ( M-N ), western blot was from an aliquot of the same sample but were run and blotted from different gels.

Article Snippet: The other primary antibodies used for western blots were as follow: anti-flag antibody (Transgen Biotech, China), anti-CDKN1A antibody (bs0741R, Bioss, China), anti-CDKN1B antibody (bs0742R, Bioss, China), anti-CDKN2B antibody (bs4269R, Bioss, China), anti-Cyclin D2 antibody (AF5410, Affinity Biosciences, USA), anti-IGF1R antibody (bs0680R, Bioss, China), anti-INSR antibody (bs0681R, Bioss, China), anti-AKT1 (#9272, Cell Signaling Technology), anti-phospho-AKT1 (#4040, Cell Signaling Technology), anti-MyoD (ab16148, Abcam), anti-MyHC (B103, Developmental Studies Hybridoma Bank), anti-HNRNPA2B1 (Fab6995, Hunan Fenghui Biotechnology), anti-GAPDH (MB001, Bioworld Technology), anti-Tubulin (MB0009, Bioworld Technology).

Techniques: Expressing, Western Blot, Cell Cycle Assay, Over Expression, Staining, Transfection, Infection, Control, Injection, Muscles, Reverse Transcription Polymerase Chain Reaction, In Vivo, In Vitro